Drug intelligence / Profile preview

fufang yinhua lishi granules

Development stage
Unknown
Lead developer
Tianchang Yifan Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Fufang Yinhua Lishi Granules (复方银花利湿颗粒) is a traditional Chinese medicine compound formulation used primarily for the treatment of symptoms associated with upper respiratory tract infections, such as those seen in common cold and influenza. The formula typically contains multiple herbal ingredients, including honeysuckle (金银花), which is known for its heat-clearing and detoxifying properties. The preparation aims to clear heat, resolve dampness, relieve exterior syndromes (such as fever and chills), and detoxify the body. It is commonly used in China for symptomatic relief of fever, sore throat, cough, nasal congestion, headache, muscle aches—especially when these are attributed to "wind-heat" or "damp-heat" patterns according to traditional Chinese medicine theory[3]. Its mechanism of action involves anti-inflammatory effects and possible antiviral activity due to its herbal components.

Other names
复方银花利湿颗粒
02

Targets

TLR7 (Toll-like receptor 7)

Beyond the preview

Go deeper on fufang yinhua lishi granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fufang yinhua lishi granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call